 | • レポートコード：QYR9N7815 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、薬理ゲノミクス（PGx）のグローバル市場について調査・分析したレポートで、種類別（ポリメラーゼ連鎖反応（PCR）、マイクロアレイ、シーケンシング、その他）、用途別（心血管疾患（CVD）、中枢神経系（CNS）、がん/腫瘍学、感染症、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・薬理ゲノミクス（PGx）の世界市場規模 ・主要企業別市場シェア ・薬理ゲノミクス（PGx）の世界市場規模：種類別（ポリメラーゼ連鎖反応（PCR）、マイクロアレイ、シーケンシング、その他） ・薬理ゲノミクス（PGx）の世界市場規模：用途別（心血管疾患（CVD）、中枢神経系（CNS）、がん/腫瘍学、感染症、その他） ・薬理ゲノミクス（PGx）のアメリカ市場規模（種類別、用途別） ・薬理ゲノミクス（PGx）のヨーロッパ市場規模（種類別、用途別） ・薬理ゲノミクス（PGx）の中国市場規模（種類別、用途別） ・薬理ゲノミクス（PGx）の日本市場規模（種類別、用途別） ・薬理ゲノミクス（PGx）の東南アジア市場規模（種類別、用途別） ・薬理ゲノミクス（PGx）のインド市場規模（種類別、用途別） ・薬理ゲノミクス（PGx）の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・薬理ゲノミクス（PGx）の世界市場予測（2019年-2025年） ・薬理ゲノミクス（PGx）の地域別市場予測（2019年-2025年） ... |
Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs.In 2018, the global Pharmacogenomics (PGx) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Pharmacogenomics (PGx) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmacogenomics (PGx) development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Affymetrix, Inc.
Assurex Health, Inc
Astrazeneca
GeneDX
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
Pathway Genomics
Pfizer, Inc
Qiagen, Inc.
Rocheg
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
Transgenomic, Inc.
Market segment by Type, the product can be split into
Polymerase Chain Reaction (PCR)
Microarray
Sequencing
Other
Market segment by Application, split into
Cardiovascular Diseases (CVD)
Central Nervous System (CNS)
Cancer/Oncology
Infectious Diseases
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Pharmacogenomics (PGx) status, future forecast, growth opportunity, key market and key players.
To present the Pharmacogenomics (PGx) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Pharmacogenomics (PGx) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pharmacogenomics (PGx) Market Size Growth Rate by Type (2014-2025)
1.4.2 Polymerase Chain Reaction (PCR)
1.4.3 Microarray
1.4.4 Sequencing
1.4.5 Other
1.5 Market by Application
1.5.1 Global Pharmacogenomics (PGx) Market Share by Application (2014-2025)
1.5.2 Cardiovascular Diseases (CVD)
1.5.3 Central Nervous System (CNS)
1.5.4 Cancer/Oncology
1.5.5 Infectious Diseases
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Pharmacogenomics (PGx) Market Size
2.2 Pharmacogenomics (PGx) Growth Trends by Regions
2.2.1 Pharmacogenomics (PGx) Market Size by Regions (2014-2025)
2.2.2 Pharmacogenomics (PGx) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Pharmacogenomics (PGx) Market Size by Manufacturers
3.1.1 Global Pharmacogenomics (PGx) Revenue by Manufacturers (2014-2019)
3.1.2 Global Pharmacogenomics (PGx) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pharmacogenomics (PGx) Market Concentration Ratio (CR5 and HHI)
3.2 Pharmacogenomics (PGx) Key Players Head office and Area Served
3.3 Key Players Pharmacogenomics (PGx) Product/Solution/Service
3.4 Date of Enter into Pharmacogenomics (PGx) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Pharmacogenomics (PGx) Market Size by Type (2014-2019)
4.2 Global Pharmacogenomics (PGx) Market Size by Application (2014-2019)
5 United States
5.1 United States Pharmacogenomics (PGx) Market Size (2014-2019)
5.2 Pharmacogenomics (PGx) Key Players in United States
5.3 United States Pharmacogenomics (PGx) Market Size by Type
5.4 United States Pharmacogenomics (PGx) Market Size by Application
6 Europe
6.1 Europe Pharmacogenomics (PGx) Market Size (2014-2019)
6.2 Pharmacogenomics (PGx) Key Players in Europe
6.3 Europe Pharmacogenomics (PGx) Market Size by Type
6.4 Europe Pharmacogenomics (PGx) Market Size by Application
7 China
7.1 China Pharmacogenomics (PGx) Market Size (2014-2019)
7.2 Pharmacogenomics (PGx) Key Players in China
7.3 China Pharmacogenomics (PGx) Market Size by Type
7.4 China Pharmacogenomics (PGx) Market Size by Application
8 Japan
8.1 Japan Pharmacogenomics (PGx) Market Size (2014-2019)
8.2 Pharmacogenomics (PGx) Key Players in Japan
8.3 Japan Pharmacogenomics (PGx) Market Size by Type
8.4 Japan Pharmacogenomics (PGx) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Pharmacogenomics (PGx) Market Size (2014-2019)
9.2 Pharmacogenomics (PGx) Key Players in Southeast Asia
9.3 Southeast Asia Pharmacogenomics (PGx) Market Size by Type
9.4 Southeast Asia Pharmacogenomics (PGx) Market Size by Application
10 India
10.1 India Pharmacogenomics (PGx) Market Size (2014-2019)
10.2 Pharmacogenomics (PGx) Key Players in India
10.3 India Pharmacogenomics (PGx) Market Size by Type
10.4 India Pharmacogenomics (PGx) Market Size by Application
11 Central & South America
11.1 Central & South America Pharmacogenomics (PGx) Market Size (2014-2019)
11.2 Pharmacogenomics (PGx) Key Players in Central & South America
11.3 Central & South America Pharmacogenomics (PGx) Market Size by Type
11.4 Central & South America Pharmacogenomics (PGx) Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pharmacogenomics (PGx) Introduction
12.1.4 Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Affymetrix, Inc.
12.2.1 Affymetrix, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pharmacogenomics (PGx) Introduction
12.2.4 Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2014-2019)
12.2.5 Affymetrix, Inc. Recent Development
12.3 Assurex Health, Inc
12.3.1 Assurex Health, Inc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pharmacogenomics (PGx) Introduction
12.3.4 Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2014-2019)
12.3.5 Assurex Health, Inc Recent Development
12.4 Astrazeneca
12.4.1 Astrazeneca Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pharmacogenomics (PGx) Introduction
12.4.4 Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2014-2019)
12.4.5 Astrazeneca Recent Development
12.5 GeneDX
12.5.1 GeneDX Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pharmacogenomics (PGx) Introduction
12.5.4 GeneDX Revenue in Pharmacogenomics (PGx) Business (2014-2019)
12.5.5 GeneDX Recent Development
12.6 Illumina, Inc.
12.6.1 Illumina, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pharmacogenomics (PGx) Introduction
12.6.4 Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2014-2019)
12.6.5 Illumina, Inc. Recent Development
12.7 Laboratory Corporation of America Holdings
12.7.1 Laboratory Corporation of America Holdings Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pharmacogenomics (PGx) Introduction
12.7.4 Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2014-2019)
12.7.5 Laboratory Corporation of America Holdings Recent Development
12.8 Myriad Genetics, Inc.
12.8.1 Myriad Genetics, Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pharmacogenomics (PGx) Introduction
12.8.4 Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2014-2019)
12.8.5 Myriad Genetics, Inc. Recent Development
12.9 Pathway Genomics
12.9.1 Pathway Genomics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pharmacogenomics (PGx) Introduction
12.9.4 Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2014-2019)
12.9.5 Pathway Genomics Recent Development
12.10 Pfizer, Inc
12.10.1 Pfizer, Inc Company Details
12.10.2 Company Description and Business Overview
12.10.3 Pharmacogenomics (PGx) Introduction
12.10.4 Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2014-2019)
12.10.5 Pfizer, Inc Recent Development
12.11 Qiagen, Inc.
12.12 Rocheg
12.13 Teva Pharmaceutical Industries Ltd.
12.14 Thermo Fisher Scientific
12.15 Transgenomic, Inc.
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.3 Author Details
List of Tables and Figures
Table Pharmacogenomics (PGx) Key Market Segments
Table Key Players Pharmacogenomics (PGx) Covered
Table Global Pharmacogenomics (PGx) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Pharmacogenomics (PGx) Market Size Market Share by Type 2014-2025
Figure Polymerase Chain Reaction (PCR) Figures
Table Key Players of Polymerase Chain Reaction (PCR)
Figure Microarray Figures
Table Key Players of Microarray
Figure Sequencing Figures
Table Key Players of Sequencing
Figure Other Figures
Table Key Players of Other
Table Global Pharmacogenomics (PGx) Market Size Growth by Application 2014-2025 (Million US$)
Figure Cardiovascular Diseases (CVD) Case Studies
Figure Central Nervous System (CNS) Case Studies
Figure Cancer/Oncology Case Studies
Figure Infectious Diseases Case Studies
Figure Other Case Studies
Figure Pharmacogenomics (PGx) Report Years Considered
Table Global Pharmacogenomics (PGx) Market Size 2014-2025 (Million US$)
Figure Global Pharmacogenomics (PGx) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Pharmacogenomics (PGx) Market Size by Regions 2014-2025 (Million US$)
Table Global Pharmacogenomics (PGx) Market Size by Regions 2014-2019 (Million US$)
Table Global Pharmacogenomics (PGx) Market Share by Regions 2014-2019
Figure Global Pharmacogenomics (PGx) Market Share by Regions 2014-2019
Figure Global Pharmacogenomics (PGx) Market Share by Regions 2019
Table Market Top Trends
Table Global Pharmacogenomics (PGx) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Pharmacogenomics (PGx) Market Share by Manufacturers (2014-2019)
Figure Global Pharmacogenomics (PGx) Market Share by Manufacturers in 2018
Table Global Pharmacogenomics (PGx) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Pharmacogenomics (PGx) Product/Solution/Service
Table Date of Enter into Pharmacogenomics (PGx) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Pharmacogenomics (PGx) Market Size by Type (2014-2019) (Million US$)
Table Global Pharmacogenomics (PGx) Market Size Share by Type (2014-2019)
Figure Global Pharmacogenomics (PGx) Market Size Market Share by Type (2014-2019)
Table Global Pharmacogenomics (PGx) Market Size by Application (2014-2019) (Million US$)
Table Global Pharmacogenomics (PGx) Market Size Share by Application (2014-2019)
Figure Global Pharmacogenomics (PGx) Market Size Market Share by Application (2014-2019)
Figure Global Pharmacogenomics (PGx) Revenue Market Share by Application in 2018
Figure United States Pharmacogenomics (PGx) Market Size 2014-2019 (Million US$)
Table United States Key Players Pharmacogenomics (PGx) Revenue (2018-2019) (Million US$)
Table United States Key Players Pharmacogenomics (PGx) Market Share (2018-2019)
Table United States Pharmacogenomics (PGx) Market Size by Type (2014-2019) (Million US$)
Table United States Pharmacogenomics (PGx) Market Share by Type (2014-2019)
Table United States Pharmacogenomics (PGx) Market Size by Application (2014-2019) (Million US$)
Table United States Pharmacogenomics (PGx) Market Share by Application (2014-2019)
Figure Europe Pharmacogenomics (PGx) Market Size 2014-2019 (Million US$)
Table Europe Key Players Pharmacogenomics (PGx) Revenue (2018-2019) (Million US$)
Table Europe Key Players Pharmacogenomics (PGx) Market Share (2018-2019)
Table Europe Pharmacogenomics (PGx) Market Size by Type (2014-2019) (Million US$)
Table Europe Pharmacogenomics (PGx) Market Share by Type (2014-2019)
Table Europe Pharmacogenomics (PGx) Market Size by Application (2014-2019) (Million US$)
Table Europe Pharmacogenomics (PGx) Market Share by Application (2014-2019)
Figure China Pharmacogenomics (PGx) Market Size 2014-2019 (Million US$)
Table China Key Players Pharmacogenomics (PGx) Revenue (2018-2019) (Million US$)
Table China Key Players Pharmacogenomics (PGx) Market Share (2018-2019)
Table China Pharmacogenomics (PGx) Market Size by Type (2014-20189) (Million US$)
Table China Pharmacogenomics (PGx) Market Share by Type (2014-2019)
Table China Pharmacogenomics (PGx) Market Size by Application (2014-2019) (Million US$)
Table China Pharmacogenomics (PGx) Market Share by Application (2014-2019)
Figure Japan Pharmacogenomics (PGx) Market Size 2014-2019 (Million US$)
Table Japan Key Players Pharmacogenomics (PGx) Revenue (2018-2019) (Million US$)
Table Japan Key Players Pharmacogenomics (PGx) Market Share (2018-2019)
Table Japan Pharmacogenomics (PGx) Market Size by Type (2014-2019) (Million US$)
Table Japan Pharmacogenomics (PGx) Market Share by Type (2014-2019)
Table Japan Pharmacogenomics (PGx) Market Size by Application (2014-2019) (Million US$)
Table Japan Pharmacogenomics (PGx) Market Share by Application (2014-2019)
Figure Southeast Asia Pharmacogenomics (PGx) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Pharmacogenomics (PGx) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Pharmacogenomics (PGx) Market Share (2018-2019)
Table Southeast Asia Pharmacogenomics (PGx) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Pharmacogenomics (PGx) Market Share by Type (2014-2019)
Table Southeast Asia Pharmacogenomics (PGx) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Pharmacogenomics (PGx) Market Share by Application (2014-2019)
Figure India Pharmacogenomics (PGx) Market Size 2014-2019 (Million US$)
Table India Key Players Pharmacogenomics (PGx) Revenue (2018-2019) (Million US$)
Table India Key Players Pharmacogenomics (PGx) Market Share (2018-2019)
Table India Pharmacogenomics (PGx) Market Size by Type (2014-2019) (Million US$)
Table India Pharmacogenomics (PGx) Market Share by Type (2014-2019)
Table India Pharmacogenomics (PGx) Market Size by Application (2014-2019) (Million US$)
Table India Pharmacogenomics (PGx) Market Share by Application (2014-2019)
Figure Central & South America Pharmacogenomics (PGx) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Pharmacogenomics (PGx) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Pharmacogenomics (PGx) Market Share (2018-2019)
Table Central & South America Pharmacogenomics (PGx) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Pharmacogenomics (PGx) Market Share by Type (2014-2019)
Table Central & South America Pharmacogenomics (PGx) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Pharmacogenomics (PGx) Market Share by Application (2014-2019)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2014-2019) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Pharmacogenomics (PGx) Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Affymetrix, Inc. Company Details
Table Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2014-2019)(Million US$)
Figure Affymetrix, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2014-2019)
Table Affymetrix, Inc. Recent Development
Table Assurex Health, Inc Company Details
Table Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2014-2019)(Million US$)
Figure Assurex Health, Inc Revenue Growth Rate in Pharmacogenomics (PGx) Business (2014-2019)
Table Assurex Health, Inc Recent Development
Table Astrazeneca Company Details
Table Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2014-2019)(Million US$)
Figure Astrazeneca Revenue Growth Rate in Pharmacogenomics (PGx) Business (2014-2019)
Table Astrazeneca Recent Development
Table GeneDX Company Details
Table GeneDX Revenue in Pharmacogenomics (PGx) Business (2014-2019)(Million US$)
Figure GeneDX Revenue Growth Rate in Pharmacogenomics (PGx) Business (2014-2019)
Table GeneDX Recent Development
Table Illumina, Inc. Company Details
Table Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2014-2019)(Million US$)
Figure Illumina, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2014-2019)
Table Illumina, Inc. Recent Development
Table Laboratory Corporation of America Holdings Company Details
Table Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2014-2019)(Million US$)
Figure Laboratory Corporation of America Holdings Revenue Growth Rate in Pharmacogenomics (PGx) Business (2014-2019)
Table Laboratory Corporation of America Holdings Recent Development
Table Myriad Genetics, Inc. Company Details
Table Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2014-2019)(Million US$)
Figure Myriad Genetics, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2014-2019)
Table Myriad Genetics, Inc. Recent Development
Table Pathway Genomics Company Details
Table Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2014-2019)(Million US$)
Figure Pathway Genomics Revenue Growth Rate in Pharmacogenomics (PGx) Business (2014-2019)
Table Pathway Genomics Recent Development
Table Pfizer, Inc Company Details
Table Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2014-2019)(Million US$)
Figure Pfizer, Inc Revenue Growth Rate in Pharmacogenomics (PGx) Business (2014-2019)
Table Pfizer, Inc Recent Development
Table Qiagen, Inc. Company Details
Table Rocheg Company Details
Table Teva Pharmaceutical Industries Ltd. Company Details
Table Thermo Fisher Scientific Company Details
Table Transgenomic, Inc. Company Details
Table Global Pharmacogenomics (PGx) Market Size by Regions (Million US$) 2019-2025
Figure Global Pharmacogenomics (PGx) Market Size Share by Regions (2019-2025)
Figure Global Pharmacogenomics (PGx) Market Size Share by Regions in 2025
Figure United States Pharmacogenomics (PGx) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Pharmacogenomics (PGx) Market Size Forecast (2019-2025)(Million USD)
Figure China Pharmacogenomics (PGx) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Pharmacogenomics (PGx) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Pharmacogenomics (PGx) Market Size Forecast (2019-2025)(Million USD)
Figure India Pharmacogenomics (PGx) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Pharmacogenomics (PGx) Market Size Forecast (2019-2025)(Million USD)
Table Global Pharmacogenomics (PGx) Market Size by Product (2019-2025) (Million US$)
Figure Global Pharmacogenomics (PGx) Market Size by Product (2019-2025)
Figure Global Pharmacogenomics (PGx) Market Size by Product in 2025
Table Global Pharmacogenomics (PGx) Market Size by Application (2019-2025) (Million US$)
Figure Global Pharmacogenomics (PGx) Market Size by Application (2019-2025)
Figure Global Pharmacogenomics (PGx) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）市場：市場規模・現状・予測 In 2018, the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Pharmacogenomics Technology/Theranostics/Companion Diagn…- 世界のポリメラーゼ連鎖反応（PCR）試験市場：市場規模・現状・予測 Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials.In 2018, the global Polymerase Chain Reaction (PCR) Test market …
- 世界のリアルタイムポリメラーゼ連鎖反応システム市場：市場規模・現状・予測 A real-time polymerase chain reaction (Real-Time PCR), also known as quantitative polymerase chain reaction (qPCR), is a laboratory technique of molecular biology based on the polymerase chain reaction (PCR).Majorly used techniques in Real Time Polymerase Chain Reaction to detect products are sequen…
- 世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場：市場規模・現状・予測 PARP means poly (adenosine diphosphate [ADP] -ribose) polymerase. It is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain (the PAR chain) and transfers them to the target proteins. This helps to restore DNA when it is damaged. DNA can be damaged by many factors, inclu…
- 世界のリアルタイムポリメラーゼ連鎖反応（PCR）装置市場2019 The global Real-time Polymerase Chain Reaction (PCR) Machines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Real-time Polymerase Chain Reaction (PCR) Machines market status and forecast, c…